January 31 is set to mark the get started of a watershed year for the biosimilars field with the launch of Amjevita, the initial biosimilar for Humira, the world’s greatest-offering drug. Many more Humira biosimilars will also be unveiled this calendar year. But with no aid from regulators and policymakers […]